Tokyo Tape
Sign in
← Sapporo Clinical Laboratory

Quarterly report · Q3

9776.TEDINET S100SUF0
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥14.9bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥20.1bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥15.3bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥415m2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥817m2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥418m2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥1.2bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥972m2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥508m2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥891m2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥312m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥569m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥493m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥305m2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥578m2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥16.9bnat 2023-12-31Cons.Assets
Total assets¥16.5bnat 2023-03-31Cons.Assets
Total assets¥16.9bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥5.8bnat 2023-12-31Cons.Liabilities
Total liabilities¥5.6bnat 2023-03-31Cons.Liabilities
Net assets / equity¥11.1bnat 2023-12-31Cons.Net assets
Net assets / equity¥10.9bnat 2023-03-31Cons.Net assets
Net assets / equity¥10.8bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥4.0bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥3.7bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥93.672023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥25.722023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥170.532022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥147.852022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥70.532022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio64.0%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio64.1%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.2%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-12-31¥92m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-12-31¥90m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-12-31¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-12-31¥66m
jpcrp040300-q3r_E04950-000Clinical Testing Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥5.8bn
jpcrp040300-q3r_E04950-000Clinical Testing Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥5.8bn
jpcrp040300-q3r_E04950-000Clinical Testing Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥104m
jpcrp040300-q3r_E04950-000Dispensing Pharmacy Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥8.3bn
jpcrp040300-q3r_E04950-000Dispensing Pharmacy Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥8.3bn
jpcrp040300-q3r_E04950-000Dispensing Pharmacy Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥548m
jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥1.2bn
jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥722m
jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥477m
jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segmentsegment profit2023-04-01 → 2023-12-31−¥7m
—segment totalrevenue2023-04-01 → 2023-12-31¥15.2bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥14.8bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥477m
—segment totalsegment profit2023-04-01 → 2023-12-31¥645m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥15.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥14.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥480m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥711m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥75m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥73m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥49m
jpcrp040300-q3r_E04950-000Clinical Testing Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥6.4bn
jpcrp040300-q3r_E04950-000Clinical Testing Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥6.4bn
jpcrp040300-q3r_E04950-000Clinical Testing Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥532m
jpcrp040300-q3r_E04950-000Dispensing Pharmacy Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥8.0bn
jpcrp040300-q3r_E04950-000Dispensing Pharmacy Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥8.0bn
jpcrp040300-q3r_E04950-000Dispensing Pharmacy Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥601m
jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥1.2bn
jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥726m
jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥495m
jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segmentsegment profit2022-04-01 → 2022-12-31−¥8m
—segment totalrevenue2022-04-01 → 2022-12-31¥15.7bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥15.2bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥495m
—segment totalsegment profit2022-04-01 → 2022-12-31¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥15.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥15.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥498m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥1.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 389
ItemContextValueUnit
Property plant and equipmentPrior1YearInstant8449010000JPY
Property plant and equipmentCurrentQuarterInstant8297883000JPY
Other iaPrior1YearInstant89958000JPY
Other iaCurrentQuarterInstant98665000JPY
Intangible assetsPrior1YearInstant89958000JPY
Intangible assetsCurrentQuarterInstant98665000JPY
Investment securitiesPrior1YearInstant149763000JPY
Investment securitiesCurrentQuarterInstant177789000JPY
Long term loans receivablePrior1YearInstant－JPY
Long term loans receivableCurrentQuarterInstant475000JPY
Long term prepaid expensesPrior1YearInstant4169000JPY
Long term prepaid expensesCurrentQuarterInstant3865000JPY
Guarantee deposits ioaPrior1YearInstant164486000JPY
Guarantee deposits ioaCurrentQuarterInstant152113000JPY
Deferred tax assetsPrior1YearInstant146473000JPY
Deferred tax assetsCurrentQuarterInstant141403000JPY
Other ioaPrior1YearInstant223373000JPY
Other ioaCurrentQuarterInstant205652000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-16841000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-22369000JPY
Investments and other assetsPrior1YearInstant671426000JPY
Investments and other assetsCurrentQuarterInstant658930000JPY
Noncurrent assetsPrior1YearInstant9210395000JPY
Noncurrent assetsCurrentQuarterInstant9055480000JPY
AssetsPrior1YearInstant16521281000JPY
AssetsCurrentQuarterInstant16935020000JPY
Notes and accounts payable tradePrior1YearInstant2179195000JPY
Notes and accounts payable tradeCurrentQuarterInstant2543164000JPY
Current portion of long term loans payablePrior1YearInstant133692000JPY
Current portion of long term loans payableCurrentQuarterInstant135367000JPY
Lease obligations clPrior1YearInstant127602000JPY
Lease obligations clCurrentQuarterInstant125308000JPY
Income taxes payablePrior1YearInstant89644000JPY
Income taxes payableCurrentQuarterInstant100011000JPY
Provision for bonusesPrior1YearInstant125073000JPY
Provision for bonusesCurrentQuarterInstant31345000JPY
Accounts payable otherPrior1YearInstant303901000JPY
Accounts payable otherCurrentQuarterInstant268235000JPY
Asset retirement obligations clPrior1YearInstant－JPY
Asset retirement obligations clCurrentQuarterInstant10000000JPY
Other clPrior1YearInstant297404000JPY
Other clCurrentQuarterInstant376905000JPY
Current liabilitiesPrior1YearInstant3256514000JPY
Current liabilitiesCurrentQuarterInstant3590337000JPY
Long term loans payablePrior1YearInstant1598629000JPY
Long term loans payableCurrentQuarterInstant1498360000JPY
Lease obligations nclPrior1YearInstant569426000JPY
Lease obligations nclCurrentQuarterInstant496114000JPY
Provision for directors retirement benefitsPrior1YearInstant69592000JPY
Provision for directors retirement benefitsCurrentQuarterInstant67864000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass